SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹1,765 Cr | ₹1,465 Cr | ₹1,273 Cr | ₹936 Cr | ₹615 Cr |
What is the latest Profit & Loss Account Balance ratio of SUVEN PHARMACEUTICALS ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹1,765 Cr |
Mar2023 | ₹1,465 Cr |
Mar2022 | ₹1,273 Cr |
Mar2021 | ₹936 Cr |
Mar2020 | ₹615 Cr |
How is Profit & Loss Account Balance of SUVEN PHARMACEUTICALS Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹1,765 Cr | 20.47 | |
Mar2023 | ₹1,465 Cr | 15.12 | |
Mar2022 | ₹1,273 Cr | 35.90 | |
Mar2021 | ₹936 Cr | 52.17 | |
Mar2020 | ₹615 Cr | - |
Compare Profit & Loss Account Balance of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹29,733.5 Cr | 11.1% | 2% | 91.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 11.1% |
2% |
91.6% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses